Copyright Reports & Markets. All rights reserved.

Global Iodixanol Injection Market Research Report 2021

Buy now

1 Iodixanol Injection Market Overview

  • 1.1 Product Overview and Scope of Iodixanol Injection
  • 1.2 Iodixanol Injection Segment by Type
    • 1.2.1 Global Iodixanol Injection Sales Growth Rate Comparison by Type (2021-2027)
    • 1.2.2 150 mg I/mL
    • 1.2.3 270 mg I/mL
    • 1.2.4 320 mg I/mL
    • 1.2.5 Others
  • 1.3 Iodixanol Injection Segment by Application
    • 1.3.1 Global Iodixanol Injection Sales Comparison by Application: (2021-2027)
    • 1.3.2 Hospitals
    • 1.3.3 Clinics
  • 1.4 Global Iodixanol Injection Market Size Estimates and Forecasts
    • 1.4.1 Global Iodixanol Injection Revenue 2016-2027
    • 1.4.2 Global Iodixanol Injection Sales 2016-2027
    • 1.4.3 Iodixanol Injection Market Size by Region: 2016 Versus 2021 Versus 2027

2 Iodixanol Injection Market Competition by Manufacturers

  • 2.1 Global Iodixanol Injection Sales Market Share by Manufacturers (2016-2021)
  • 2.2 Global Iodixanol Injection Revenue Market Share by Manufacturers (2016-2021)
  • 2.3 Global Iodixanol Injection Average Price by Manufacturers (2016-2021)
  • 2.4 Manufacturers Iodixanol Injection Manufacturing Sites, Area Served, Product Type
  • 2.5 Iodixanol Injection Market Competitive Situation and Trends
    • 2.5.1 Iodixanol Injection Market Concentration Rate
    • 2.5.2 The Global Top 5 and Top 10 Largest Iodixanol Injection Players Market Share by Revenue
    • 2.5.3 Global Iodixanol Injection Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
  • 2.6 Manufacturers Mergers & Acquisitions, Expansion Plans

3 Iodixanol Injection Retrospective Market Scenario by Region

  • 3.1 Global Iodixanol Injection Retrospective Market Scenario in Sales by Region: 2016-2021
  • 3.2 Global Iodixanol Injection Retrospective Market Scenario in Revenue by Region: 2016-2021
  • 3.3 North America Iodixanol Injection Market Facts & Figures by Country
    • 3.3.1 North America Iodixanol Injection Sales by Country
    • 3.3.2 North America Iodixanol Injection Revenue by Country
    • 3.3.3 United States
    • 3.3.4 Canada
  • 3.4 Europe Iodixanol Injection Market Facts & Figures by Country
    • 3.4.1 Europe Iodixanol Injection Sales by Country
    • 3.4.2 Europe Iodixanol Injection Revenue by Country
    • 3.4.3 Germany
    • 3.4.4 France
    • 3.4.5 U.K.
    • 3.4.6 Italy
    • 3.4.7 Russia
  • 3.5 Asia Pacific Iodixanol Injection Market Facts & Figures by Region
    • 3.5.1 Asia Pacific Iodixanol Injection Sales by Region
    • 3.5.2 Asia Pacific Iodixanol Injection Revenue by Region
    • 3.5.3 China
    • 3.5.4 Japan
    • 3.5.5 South Korea
    • 3.5.6 India
    • 3.5.7 Australia
    • 3.5.8 China Taiwan
    • 3.5.9 Indonesia
    • 3.5.10 Thailand
    • 3.5.11 Malaysia
  • 3.6 Latin America Iodixanol Injection Market Facts & Figures by Country
    • 3.6.1 Latin America Iodixanol Injection Sales by Country
    • 3.6.2 Latin America Iodixanol Injection Revenue by Country
    • 3.6.3 Mexico
    • 3.6.4 Brazil
    • 3.6.5 Argentina
    • 3.6.6 Colombia
  • 3.7 Middle East and Africa Iodixanol Injection Market Facts & Figures by Country
    • 3.7.1 Middle East and Africa Iodixanol Injection Sales by Country
    • 3.7.2 Middle East and Africa Iodixanol Injection Revenue by Country
    • 3.7.3 Turkey
    • 3.7.4 Saudi Arabia
    • 3.7.5 UAE

4 Global Iodixanol Injection Historic Market Analysis by Type

  • 4.1 Global Iodixanol Injection Sales Market Share by Type (2016-2021)
  • 4.2 Global Iodixanol Injection Revenue Market Share by Type (2016-2021)
  • 4.3 Global Iodixanol Injection Price by Type (2016-2021)

5 Global Iodixanol Injection Historic Market Analysis by Application

  • 5.1 Global Iodixanol Injection Sales Market Share by Application (2016-2021)
  • 5.2 Global Iodixanol Injection Revenue Market Share by Application (2016-2021)
  • 5.3 Global Iodixanol Injection Price by Application (2016-2021)

6 Key Companies Profiled

  • 6.1 GE Healthcare
    • 6.1.1 GE Healthcare Corporation Information
    • 6.1.2 GE Healthcare Description and Business Overview
    • 6.1.3 GE Healthcare Iodixanol Injection Sales, Revenue and Gross Margin (2016-2021)
    • 6.1.4 GE Healthcare Iodixanol Injection Product Portfolio
    • 6.1.5 GE Healthcare Recent Developments/Updates
  • 6.2 Hengrui Medicine
    • 6.2.1 Hengrui Medicine Corporation Information
    • 6.2.2 Hengrui Medicine Description and Business Overview
    • 6.2.3 Hengrui Medicine Iodixanol Injection Sales, Revenue and Gross Margin (2016-2021)
    • 6.2.4 Hengrui Medicine Iodixanol Injection Product Portfolio
    • 6.2.5 Hengrui Medicine Recent Developments/Updates
  • 6.3 Daiichi Sankyo
    • 6.3.1 Daiichi Sankyo Corporation Information
    • 6.3.2 Daiichi Sankyo Description and Business Overview
    • 6.3.3 Daiichi Sankyo Iodixanol Injection Sales, Revenue and Gross Margin (2016-2021)
    • 6.3.4 Daiichi Sankyo Iodixanol Injection Product Portfolio
    • 6.3.5 Daiichi Sankyo Recent Developments/Updates
  • 6.4 YRPG
    • 6.4.1 YRPG Corporation Information
    • 6.4.2 YRPG Description and Business Overview
    • 6.4.3 YRPG Iodixanol Injection Sales, Revenue and Gross Margin (2016-2021)
    • 6.4.4 YRPG Iodixanol Injection Product Portfolio
    • 6.4.5 YRPG Recent Developments/Updates
  • 6.5 BeiLu Pharma
    • 6.5.1 BeiLu Pharma Corporation Information
    • 6.5.2 BeiLu Pharma Description and Business Overview
    • 6.5.3 BeiLu Pharma Iodixanol Injection Sales, Revenue and Gross Margin (2016-2021)
    • 6.5.4 BeiLu Pharma Iodixanol Injection Product Portfolio
    • 6.5.5 BeiLu Pharma Recent Developments/Updates
  • 6.6 Cadiasun Pharma GmbH
    • 6.6.1 Cadiasun Pharma GmbH Corporation Information
    • 6.6.2 Cadiasun Pharma GmbH Description and Business Overview
    • 6.6.3 Cadiasun Pharma GmbH Iodixanol Injection Sales, Revenue and Gross Margin (2016-2021)
    • 6.6.4 Cadiasun Pharma GmbH Iodixanol Injection Product Portfolio
    • 6.6.5 Cadiasun Pharma GmbH Recent Developments/Updates

7 Iodixanol Injection Manufacturing Cost Analysis

  • 7.1 Iodixanol Injection Key Raw Materials Analysis
    • 7.1.1 Key Raw Materials
    • 7.1.2 Key Suppliers of Raw Materials
  • 7.2 Proportion of Manufacturing Cost Structure
  • 7.3 Manufacturing Process Analysis of Iodixanol Injection
  • 7.4 Iodixanol Injection Industrial Chain Analysis

8 Marketing Channel, Distributors and Customers

  • 8.1 Marketing Channel
  • 8.2 Iodixanol Injection Distributors List
  • 8.3 Iodixanol Injection Customers

9 Iodixanol Injection Market Dynamics

  • 9.1 Iodixanol Injection Industry Trends
  • 9.2 Iodixanol Injection Growth Drivers
  • 9.3 Iodixanol Injection Market Challenges
  • 9.4 Iodixanol Injection Market Restraints

10 Global Market Forecast

  • 10.1 Iodixanol Injection Market Estimates and Projections by Type
    • 10.1.1 Global Forecasted Sales of Iodixanol Injection by Type (2022-2027)
    • 10.1.2 Global Forecasted Revenue of Iodixanol Injection by Type (2022-2027)
  • 10.2 Iodixanol Injection Market Estimates and Projections by Application
    • 10.2.1 Global Forecasted Sales of Iodixanol Injection by Application (2022-2027)
    • 10.2.2 Global Forecasted Revenue of Iodixanol Injection by Application (2022-2027)
  • 10.3 Iodixanol Injection Market Estimates and Projections by Region
    • 10.3.1 Global Forecasted Sales of Iodixanol Injection by Region (2022-2027)
    • 10.3.2 Global Forecasted Revenue of Iodixanol Injection by Region (2022-2027)

11 Research Finding and Conclusion

    12 Methodology and Data Source

    • 12.1 Methodology/Research Approach
      • 12.1.1 Research Programs/Design
      • 12.1.2 Market Size Estimation
      • 12.1.3 Market Breakdown and Data Triangulation
    • 12.2 Data Source
      • 12.2.1 Secondary Sources
      • 12.2.2 Primary Sources
    • 12.3 Author List

    The research report includes specific segments by region (country), by company, by Type and by Application. This study provides information about the sales and revenue during the historic and forecasted period of 2016 to 2027. Understanding the segments helps in identifying the importance of different factors that aid the market growth.

    Segment by Type
    150 mg I/mL
    270 mg I/mL
    320 mg I/mL
    Others

    Segment by Application
    Hospitals
    Clinics

    By Region
    North America
    United States
    Canada
    Europe
    Germany
    France
    U.K.
    Italy
    Russia
    Asia-Pacific
    China
    Japan
    South Korea
    India
    Australia
    China Taiwan
    Indonesia
    Thailand
    Malaysia
    Latin America
    Mexico
    Brazil
    Argentina
    Colombia
    Middle East & Africa
    Turkey
    Saudi Arabia
    UAE

    By Company
    GE Healthcare
    Hengrui Medicine
    Daiichi Sankyo
    YRPG
    BeiLu Pharma
    Cadiasun Pharma GmbH

    Buy now